Paydirt
GRCE
Ticker

Grace Therapeutics, Inc.

GRCE · Healthcare · Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada

Grace Therapeutics, Inc. (GRCE), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 2 purchases and 0 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Oct 26 and filed Oct 26. The most active filer was Prashant Kohli with 1 filing. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
2
2 buys · 0 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$331K
estimated for Congress, as filed for insiders
Median delay
0d
execution to disclosure
Last traded
Oct 26
Filed Oct 26
ADViAverage daily dollar volume
$466K
market data
Share price · 12M
$1.94 (-35.1%)
$5.13$3.47$1.81Nov 10 2025May 7Oct 30

Adjusted for splits and dividends.

Volume by month
$214K$107K$0Dec 2024Jun 2025Dec 2025Jun 2026Sep 2026 · buys $214KOct 2026 · buys $117K
Buys $331K Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
PK Prashant Kohli Chief Executive Officer 1 filing · 1 buy, 0 sales OI Opaleye Management Inc. 10% owner 1 filing · 1 buy, 0 sales
Recent filings
Opaleye Management Inc.PURCHASE 10% owner $117K
66,411 sh × $1.77
Exec Oct 26
Filed Oct 26 · 6:06 PM ET Prashant KohliPURCHASE Chief Executive Officer $214K
100,000 sh × $2.14
Exec Sep 9
Filed Sep 10 · 7:30 AM ET